La production d'énergie à l'horizon 2010

Autor: Hélène Chaudière, Business China

Publikováno v: Perspectives chinoises. 24:31-33

Business China, Chaudière Hélène. La production d'énergie à l'horizon 2010. In: Perspectives chinoises, n°24, 1994. pp. 31-33.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ba63d3889dbd6816827db104454b39
https://doi.org/10.3406/perch.1994.4146

Commerce : vers le redressement ?

Autor: Business China, Hélène Chaudière

Publikováno v: Perspectives chinoises. 24:28-30

Business China, Chaudière Hélène. Commerce : vers le redressement ?. In: Perspectives chinoises, n°24, 1994. pp. 28-30.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f6feb6f66afd80ec1315dec41feed2
https://doi.org/10.3406/perch.1994.4145

Une foi aveugle. Quelques conseils à ceux qui souhaitent investir en Chine

Autor: Hélène Chaudière, Business China

Publikováno v: Périodiques Scientifiques en Édition Électronique.

Business China, Chaudière Hélène. Une foi aveugle. Quelques conseils à ceux qui souhaitent investir en Chine. In: Perspectives chinoises, n°20, 1993. pp. 9-10.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02995f92e082fbe1dd39ccddfee0e036
https://www.persee.fr/doc/perch_1021-9013_1993_num_20_1_4051

Clinical outcomes, management, healthcare resource utilization, and cost according to the CHA 2 DS 2 -VASc scores in Asian patients with nonvalvular atrial fibrillation.

Autor: Fan K; School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China., Xiao Y; School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China., Xue A; School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China., Zhou J; School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China. Electronic address: 1020202613@cpu.edu.cn.

Publikováno v: International journal of cardiology [Int J Cardiol] 2024 Dec 15; Vol. 417, pp. 132496. Date of Electronic Publication: 2024 Aug 28.

Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China.

Autor: Gu P; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China., Lu P; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China., Ding H; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China., Liu Q; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China., Ding X; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China., Chen Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China., Zhu L; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China.

Publikováno v: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2344821. Date of Electronic Publication: 2024 May 02.